Role of homocysteine in end-stage renal disease
Authors:
- Chia-Chao WuChia-Chao Wu
- Cai-Mei ZhengCZCai-Mei Zheng
- Yuh-Feng LinYLYuh-Feng Lin
- Lan LoLLLan Lo
- Min-Tser LiaoMLMin-Tser Liao
- Kuo-Cheng LuKLKuo-Cheng Lu
- 1 November 2012
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 45 (16-17) , 1286-1294
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan (100-2314-B-016-027)
- Tri-Service General Hospital (TSGH-C101-009-S04)
This publication has 113 references indexed in Scilit:
- Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trialsThe Lancet, 2011
- Dietary B Vitamin and Methionine Intakes and Breast Cancer Risk Among Chinese WomenAmerican Journal of Epidemiology, 2011
- Homocysteine as a Risk Factor for Cardiovascular Disease in Patients Treated by Dialysis: A Meta–analysisAmerican Journal of Kidney Diseases, 2009
- Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2009
- Role of homocysteine in aortic calcification and osteogenic cell differentiationAtherosclerosis, 2009
- Factors associated with serum total homocysteine level in type 2 diabetesEnvironmental Health and Preventive Medicine, 2008
- Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus PatientsMediators of Inflammation, 2007
- Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?BMJ, 2005
- C-reactive protein and cardiovascular disease in peritoneal dialysis patientsKidney International, 2002
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000